North Star Investment Management’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,000
Closed -$38K 1330
2022
Q3
$38K Hold
20,000
﹤0.01% 587
2022
Q2
$51K Hold
20,000
﹤0.01% 545
2022
Q1
$69K Hold
20,000
0.01% 525
2021
Q4
$96K Hold
20,000
0.01% 490
2021
Q3
$73K Hold
20,000
0.01% 516
2021
Q2
$81K Hold
20,000
0.01% 508
2021
Q1
$86K Sell
20,000
-1,000
-5% -$4.78K 0.01% 469
2020
Q4
$83K Hold
21,000
0.01% 459
2020
Q3
$77K Buy
21,000
+1,000
+5% +$4.22K 0.01% 447
2020
Q2
$68K Hold
20,000
0.01% 447
2020
Q1
$27K Hold
20,000
﹤0.01% 590
2019
Q4
$29K Hold
20,000
﹤0.01% 658
2019
Q3
$42K Hold
20,000
﹤0.01% 585
2019
Q2
$49K Sell
20,000
-10,000
-33% -$21.8K 0.01% 387
2019
Q1
$78K Hold
30,000
0.01% 480
2018
Q4
$90K Hold
30,000
0.01% 424
2018
Q3
$104K Hold
30,000
0.01% 438
2018
Q2
$141K Hold
30,000
0.02% 400
2018
Q1
$95K Hold
30,000
0.01% 453
2017
Q4
$147K Hold
30,000
0.02% 385
2017
Q3
$206K Hold
30,000
0.03% 350
2017
Q2
$197K Hold
30,000
0.03% 349
2017
Q1
$240K Hold
30,000
0.03% 319
2016
Q4
$279K Buy
+30,000
New +$310K 0.04% 286

Other funds holding OPK

North Star Investment Management's OPK Position: Q4 2022 in Review

North Star Investment Management sold out of Opko Health (OPK) in Q4 2022, closing a stake of 20,000 shares — an estimated $38K sold.

North Star Investment Management first reported a position in OPK in Q4 2016 and held it in 24 quarters. The position peaked at $279K in Q4 2016. 221 funds tracked by Wall St. Rank hold OPK as of Q4 2022.

  • North Star Investment Management reported no remaining Opko Health position as of Q4 2022 after selling out during the quarter.
  • North Star Investment Management sold 20,000 Opko Health shares in Q4 2022, an estimated $38K.
  • North Star Investment Management first reported a position in Opko Health in Q4 2016 and held it in 24 quarters.
  • North Star Investment Management's Opko Health position peaked at $279K in Q4 2016.
  • 221 funds tracked by Wall St. Rank held Opko Health as of Q4 2022.

Based on North Star Investment Management's 13F filing for Q4 2022, filed 11 Jan 2023.